Investigation of tumor biomarkers as response predictors in a monotherapy study with lapatinib (L) as a first line treatment in ErbB2 amplified women with breast cancer
Year: 2007
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: H. L. Gomez, M. A. Chavez, D. C. Doval, S. Franco, M. Arbushites, M. S. Berger, M. A. Casey, S. Stein, T. Zaks, A. M. Martin
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2966425610
